[144] Legend Biotech Corp SEC Filing

Rhea-AI Filing Summary

Legend Biotech Corp (LEGN) Form 144 summary: An insider plans to sell 474 American Depositary Shares on 09/23/2025 through Fidelity Brokerage Services. The shares were acquired on 09/19/2025 by Restricted Stock Vesting and were paid as compensation. The aggregate market value of the proposed sale is listed as $16,106.85, with the issuer's outstanding shares shown as 367,298,315. The filing also discloses a prior sale by the same person: 642 ADS sold on 07/23/2025 for $28,890.00. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Positive

• The securities to be sold were acquired via Restricted Stock Vesting on 09/19/2025, with payment noted as compensation.
• The filing discloses a prior sale by the same person: 642 ADS sold on 07/23/2025 for $28,890.00, showing recent transaction history.

Negative

• The proposed sale reduces the holder's position by 474 ADS with an aggregate market value of $16,106.85.
• No additional context on the significance of the disposition relative to total insider holdings is provided in the filing.

Insights

Securities Analyst

TL;DR: Insider sale is routine: 474 ADS from recent restricted stock vesting to be sold via brokerage on 09/23/2025.

The Form 144 reports a proposed sale of 474 American Depositary Shares acquired two days earlier through restricted stock vesting and paid as compensation. The transaction is to be executed through Fidelity Brokerage Services with an aggregate market value of $16,106.85. A prior sale of 642 ADS on 07/23/2025 for $28,890.00 is disclosed. Based solely on the filing's facts, this represents individual insider disposition activity rather than company-level operating or financial developments. No additional financial metrics or contextual details about company performance are provided in the document.

Corporate Governance Expert

TL;DR: The filing documents a compensation-related vesting sale; the signer affirms no undisclosed material adverse information.

The document shows the securities to be sold were acquired by restricted stock vesting and the payment type is listed as compensation, indicating the disposition relates to insider compensation mechanics. The filer includes the standard representation that they do not know of material adverse information not publicly disclosed. The filing does not include information about board actions, policy changes, or broader governance developments.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	474	16106.85	367298315	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	09/19/2025	Restricted Stock Vesting	Issuer			474	09/19/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessie Yeung 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	07/23/2025	642	28890.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LEGN Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 474 American Depositary Shares on 09/23/2025 through Fidelity Brokerage Services with an aggregate market value of $16,106.85.

How were the shares to be sold acquired according to the Form 144?

The shares were acquired on 09/19/2025 by Restricted Stock Vesting and the nature of payment is listed as compensation.

Did the filer disclose any recent sales in the past three months for LEGN?

Yes, the filing lists a prior sale by Jessie Yeung of 642 ADS on 07/23/2025 generating gross proceeds of $28,890.00.

Through which broker will the LEGN shares be sold?

The proposed sale is to be executed through Fidelity Brokerage Services LLC located at the address provided in the filing.

Does the filer state anything about undisclosed material information?

By signing, the person represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.